Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2021 Filed Oct 14, 2021 22:29 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 423 | $407.29 | $172,283.67 |
DisclosureSEC source: 0001127602-21-027096 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,960 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 423 shares sold ranging from $406.76 to $407.69 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Cancel Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 20:54 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
Tax withholdingCommon Stock | 115 | $387.98 | $44,617.70 |
DisclosureSEC source: 0001127602-21-026804 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,053 F1 · balance_after: Balance includes 56 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| October 05, 2021 Filed Nov 9, 2021 22:05 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 83 | $387.98 | $32,202.34 |
DisclosureSEC source: 0001127602-21-028726 · form4.xml · nonDerivative · entry 1 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,484 Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:04 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $418.04 | $41,804.00 |
DisclosureSEC source: 0001127602-21-026089 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,356 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 20:24 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $436.69 | $137,120.66 |
DisclosureSEC source: 0001127602-21-025721 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 4,972 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 23:15 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 300 | $463.50 | $139,050.00 |
DisclosureSEC source: 0001127602-21-024710 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,456 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:40 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $489.10 | $153,577.40 |
DisclosureSEC source: 0001127602-21-024312 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 5,286 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance includes 24 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| August 18, 2021 Filed Sep 3, 2021 23:17 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
Tax withholdingCommon Stock | 9,949 | $510.61 | $5,080,058.89 |
DisclosureSEC source: 0001127602-21-024923 · form4.xml · nonDerivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,383 F2 · shares: Represents tax withholding, required pursuant to the terms of the Merger Agreement, in connection with the shares received in respect of the GRAIL stock options held by the reporting person as of immediately prior to the Closing. Read SEC document |
| August 18, 2021 Filed Sep 3, 2021 23:17 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantCommon Stock | 21,653 | $510.61 | $11,056,238.33 |
DisclosureSEC source: 0001127602-21-024923 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,332 F1 · shares: Represents shares acquired by the reporting person pursuant to the terms of the Agreement and Plan of Merger, dated as of September 20, 2020, as amended, by and among Illumina, Inc. and GRAIL, Inc. ("GRAIL"), among others (the "Merger Agreement"). At the closing of the transactions contemplated by the Merger Agreement (the "Closing"), the reporting person became entitled to receive in respect of the shares of Class A Common Stock of GRAIL and GRAIL stock options held by him as of immediately prior to the Closing the shares of Illumina common stock reported above, based on, in each case, an exchange ratio determined pursuant to the terms of the Merger Agreement. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 20:22 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 1,000 | $500.00 | $500,000.00 |
DisclosureSEC source: 0001127602-21-023156 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,756 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance includes 13 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| August 04, 2021 Filed Sep 8, 2021 23:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 372 | $500.00 | $186,000.00 |
DisclosureSEC source: 0001127602-21-025043 · form4.xml · nonDerivative · entry 6 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,757 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance includes 18 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Jul 29, 2021 20:34 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 300 | $486.41 | $145,923.00 |
DisclosureSEC source: 0001127602-21-022606 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,743 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:57 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $482.23 | $151,420.22 |
DisclosureSEC source: 0001127602-21-022498 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 5,576 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| July 07, 2021 Filed Jul 7, 2021 22:26 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 539 | $477.59 | $257,421.01 |
DisclosureSEC source: 0001127602-21-021690 · form4.xml · nonDerivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,679 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 22:26 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
Tax withholdingCommon Stock | 285 | $474.85 | $135,332.25 |
DisclosureSEC source: 0001127602-21-021690 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,218 Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 21:27 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 300 | $478.95 | $143,685.00 |
DisclosureSEC source: 0001127602-21-020865 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,043 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 24, 2021 Filed Sep 8, 2021 23:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 500 | $475.00 | $237,500.00 |
DisclosureSEC source: 0001127602-21-025043 · form4.xml · nonDerivative · entry 5 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,111 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 21:41 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $461.01 | $144,757.14 |
DisclosureSEC source: 0001127602-21-020607 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 5,890 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 21:50 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
SaleCommon Stock | 290 | $449.02 | $130,215.80 |
DisclosureSEC source: 0001127602-21-019827 · form4.xml · nonDerivative · entry 3 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,461 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 21:50 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
SaleCommon Stock | 400 | $447.65 | $179,060.00 |
DisclosureSEC source: 0001127602-21-019827 · form4.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,751 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 400 shares sold ranging from $447.28 to $448.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 21:50 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
SaleCommon Stock | 310 | $446.17 | $138,312.70 |
DisclosureSEC source: 0001127602-21-019827 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,151 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 310 shares sold ranging from $446.14 to $446.24 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:48 UTC |
DORSA CAROLINEDirector
|
SaleCommon Stock | 1,000 | $450.00 | $450,000.00 |
DisclosureSEC source: 0001127602-21-019825 · form4.xml · nonDerivative · entry 1 DORSA CAROLINE · CIK 0001181174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,501 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 10, 2021 Filed Sep 8, 2021 23:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 500 | $450.00 | $225,000.00 |
DisclosureSEC source: 0001127602-21-025043 · form4.xml · nonDerivative · entry 4 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,611 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:43 UTC |
THOMPSON JOHN WENDELLDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018219 · form4.xml · nonDerivative · entry 1 THOMPSON JOHN WENDELL · CIK 0001207433 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,930 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:40 UTC |
SCHILLER PHILIP WDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018215 · form4.xml · nonDerivative · entry 1 SCHILLER PHILIP W · CIK 0001214110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,929 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:37 UTC |
Gottlieb ScottDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018209 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,239 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:34 UTC |
ARNOLD FRANCESDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018205 · form4.xml · nonDerivative · entry 1 ARNOLD FRANCES · CIK 0001665419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,808 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:32 UTC |
SIEGEL SUSAN EDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018204 · form4.xml · nonDerivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,596 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:29 UTC |
GUTHART GARY SDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018203 · form4.xml · nonDerivative · entry 2 GUTHART GARY S · CIK 0001280628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,211 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:27 UTC |
EPSTEIN ROBERT SDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018202 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,424 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:24 UTC |
DORSA CAROLINEDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018200 · form4.xml · nonDerivative · entry 2 DORSA CAROLINE · CIK 0001181174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,501 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:32 UTC |
SIEGEL SUSAN EDirector
|
Tax withholdingCommon Stock | 385 | $397.09 | $152,879.65 |
DisclosureSEC source: 0001127602-21-018204 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,715 Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:29 UTC |
GUTHART GARY SDirector
|
Tax withholdingCommon Stock | 385 | $397.09 | $152,879.65 |
DisclosureSEC source: 0001127602-21-018203 · form4.xml · nonDerivative · entry 1 GUTHART GARY S · CIK 0001280628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,330 Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:27 UTC |
EPSTEIN ROBERT SDirector
|
Tax withholdingCommon Stock | 385 | $397.09 | $152,879.65 |
DisclosureSEC source: 0001127602-21-018202 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,543 Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:24 UTC |
DORSA CAROLINEDirector
|
Tax withholdingCommon Stock | 385 | $397.09 | $152,879.65 |
DisclosureSEC source: 0001127602-21-018200 · form4.xml · nonDerivative · entry 1 DORSA CAROLINE · CIK 0001181174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,620 Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:50 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $403.04 | $126,554.56 |
DisclosureSEC source: 0001127602-21-018067 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,204 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:43 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 500 | $400.00 | $200,000.00 |
DisclosureSEC source: 0001127602-21-017909 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,343 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:51 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $379.53 | $1,518,120.00 |
DisclosureSEC source: 0001127602-21-017616 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:26 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 300 | $381.88 | $114,564.00 |
DisclosureSEC source: 0001127602-21-015774 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,843 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:24 UTC |
TORRES JOSEVP, Chief Accounting Officer
|
GrantPerformance Shares · Derivative | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015773 · form4.xml · derivative · entry 2 TORRES JOSE · CIK 0001666638 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 793 Underlying: Common Stock · 793 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:24 UTC |
TORRES JOSEVP, Chief Accounting Officer
|
GrantCommon Stock | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015773 · form4.xml · nonDerivative · entry 1 TORRES JOSE · CIK 0001666638 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:21 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $384.15 | $1,536,600.00 |
DisclosureSEC source: 0001127602-21-015772 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 23:52 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $402.02 | $126,234.28 |
DisclosureSEC source: 0001127602-21-014490 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,518 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 21:05 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $401.83 | $1,607,320.00 |
DisclosureSEC source: 0001127602-21-014318 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:41 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $423.44 | $1,693,740.00 |
DisclosureSEC source: 0001127602-21-013417 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:34 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 500 | $423.44 | $211,717.50 |
DisclosureSEC source: 0001127602-21-013406 · form4.xml · nonDerivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,143 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 06, 2021 Filed Sep 8, 2021 23:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 500 | $423.44 | $211,717.50 |
DisclosureSEC source: 0001127602-21-025043 · form4.xml · nonDerivative · entry 3 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,111 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 06, 2021 Filed Sep 8, 2021 23:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 500 | $425.00 | $212,500.00 |
DisclosureSEC source: 0001127602-21-025043 · form4.xml · nonDerivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,611 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:38 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Tax withholdingCommon Stock | 131 | $384.54 | $50,374.74 |
DisclosureSEC source: 0001127602-21-013414 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,461 Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:34 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 300 | $386.03 | $115,809.00 |
DisclosureSEC source: 0001127602-21-013406 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,643 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.